O
Ocular Therapeutix, Inc.
OCUL · NASDAQ · Healthcare · 2.2B
Closing price
$7.54
+0.40% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.2×
Enterprise value / EBITDAEV/EBITDA
-3.0×
Free cash flow yieldFCF yield
-15.4%
Return on equityROE
-40.6%
Operating margin
-521.0%
Net debt / EBITDAbalance-sheet strength
2.6×
Interest coverage
-22.8×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.